I know you're anxious, but you of all people would think it was wise to get started a couple months down the road -- in order to see topline results from the Phase III. How many times do we see CI combos bite the dust because the combo partner's/collaborator's/buddy's trial failed? No one here is saying that can't happen. The imminent results in the Phase III trial will either be Great, Good, Somewhat Promising or an out and out failure. Opdivo themselves failed in a major trial -- but it is still a therapy that can help people. It's wise at this late stage to get some answers in the DCVax-L Phase III trial before entering people in another DCVax-L trial. IMHO.
Market Data 
Markets 
AI
